News | April 07, 2025
Dr Reddy’s Laboratories gets Rs 2,395 crore show cause notice from IT authority
Dr Reddy’s said scheme of amalgamation was carried with adherence to all the legal requirements including tax laws
Dr Reddy’s said scheme of amalgamation was carried with adherence to all the legal requirements including tax laws
The amalgamation is expected to create a future-ready, diversified CDMO platform with a technology-led focus across three high-growth verticals-Antibody Drug Conjugates
The new office in New Delhi marks a significant funding in the APAC region and reinforces the company’s commitment to advancing respiratory care in India
Amexel aims to generate revenue through facilitation services and a profit-sharing model linked to the commercialization of products
Through strong industry cooperation, significant investment, and smart policy backing, API manufacturing may become self-reliant
These appointments align with the group’s philosophy of having a strong and independent board with exceptional industry experts, ensuring strategic guidance and effective governance
Havix was incorporated under the laws of the State of Delaware on February 17, 2015
The PIPE offering consists of 36,190,476 units
Aster commits to increase bed capacity in the State via capacity expansion and greenfield projects
The FDA determined that the data presented in a 2022 color additive petition show that this ingredient causes cancer in male laboratory rats exposed to high levels of FD&C Red No. 3 because of a hormonal mechanism that occurs in male rats
Subscribe To Our Newsletter & Stay Updated
